Old Web
English
Sign In
Acemap
>
authorDetail
>
A. Tenorio
A. Tenorio
ViiV Healthcare
Medicine
Dolutegravir
Internal medicine
Lamivudine
human immunodeficiency virus
5
Papers
22
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Switching to DTG/3TC fixed-dose combination (FDC) Is non-inferior to continuing a TAF-based regimen in maintaining virologic suppression through 48 weeks (TANGO Study)
2020
Journal of Infection and Public Health
J. van Wyk
F. Ajana
F Bisshop
S De Wit
Y. Osiyemi
Joaquín Portilla
Jean-Pierre Routy
Christoph Wyen
Mounir Ait-Khaled
Maria Claudia Nascimento
K. Pappa
R. Wang
J. Wright
A. Tenorio
Brian Wynne
Michael Aboud
Martin Gartland
K. Smith
Y. El-Bahy
Show All
Source
Cite
Save
Citations (9)
Durable Efficacy of Dolutegravir (DTG) Plus Lamivudine (3TC) in Antiretroviral Treatment-Naive Adults With HIV-1 Infection: 96-Week Results From the GEMINI Studies
2020
Journal of Infection and Public Health
Pedro Cahn
J Sierra-Madero
José R. Arribas
Andrea Antinori
Roberto Ortiz
A. Clarke
Hung Cc
J. K. Rockstroh
Pierre-Marie Girard
Jörg Sievers
C. Man
Rimgaile Urbaityte
Mark Underwood
A. Tenorio
K. Pappa
Brian Wynne
Martin Gartland
Michael Aboud
J. van Wyk
K. Smith
Y. El-Bahy
Show All
Source
Cite
Save
Citations (11)
2842. Durable Efficacy of Two-Drug Regimen (2DR) of Dolutegravir (DTG) plus Lamivudine (3TC) in Antiretroviral Treatment-Naïve Adults with HIV-1 Infection at 96 Weeks: Subgroup Analyses in the GEMINI Studies
2019
Open Forum Infectious Diseases
Jean van Wyk
Choy Y Man
Jörg Sievers
Rimgaile Urbaityte
Mark Underwood
A. Tenorio
Keith Pappa
Brian Wynne
K. Smith
Martin Gartland
Show All
Source
Cite
Save
Citations (0)
Bioequivalence and Food Effect Assessment of 2 Fixed‐Dose Combination Formulations of Dolutegravir and Lamivudine
2019
Clinical pharmacology in drug development
Teodora Pene Dumitrescu
Kavita Peddiraju
Caifeng Fu
Kalpana Bakshi
Shui Yu
Zhiping Zhang
A. Tenorio
Chris Spancake
Shashidhar Joshi
Allen Wolstenholme
Kimberly Adkison
Show All
Source
Cite
Save
Citations (1)
Dolutegravir-Based Antiretroviral Therapy for the Treatment of Patients Co-Infected with Tuberculosis and HIV: A Multicenter, Phase 3B, Noncomparative, Open-Label, Randomized Trial
2018
Social Science Research Network
Kelly E. Dooley
Richard Kaplan
Noluthando Mwelase
Beatriz Grinsztejn
Eduardo Ticona
Marcus V. G. Lacerda
Omar Sued
Elena Belonosova
Mounir Ait-Khaled
Konstantinos Angelis
Dannae Brown
Rajendra P. Singh
Christine L. Talarico
A. Tenorio
Michael Keegan
Michael Aboud
Show All
Source
Cite
Save
Citations (1)
1